Bharat Biotech's Covaxin Has 81% Efficacy. Here's How it Compares to Serum Institute's Covishield
81% Interim Efficacy Data Shot in the Arm for Bharat Biotech's Covaxin Export Hopes
Covaxin Shows Interim Efficacy of 81% in Phase 3 Results, Announces Bharat Biotech
Beijing Dismisses Alleged Chinese Hacking of Bharat Biotech, Serum Institute of India
India's Covid-19 Vaccine Innovation And Development Strategy Wins WHO Praise
After Power Grid, China Hackers Also Targeted Indian Vaccine Makers for 'Competitive Advantage': Report
Bharat Biotech to Supply 20 Million Doses of Covaxin to Brazil
Drugs Controller Rejects Bharat Biotech's Request for Covid Vaccine Trials on Kids, Seeks Efficacy Data First